Nearly 90 percent of the plaintiffs in pharmaceutical product liability cases tried in California were non-residents. Contributed photo
ILR report says out-of-state plaintiffs prefer California courts
Research from the Institute for Legal Reform shows that California courts are popular among litigants seeking favorable verdicts for pharmaceutical product liability cases.
A study from the Institute released Jan. 25 shows that nearly 90 percent of the plaintiffs in such cases tried in California between January 2010 and May 2016 were non-residents of the state.
“California’s reputation as a plaintiff-friendly venue is the reason for attracting these out-of-state lawsuits to the Los Angeles and San Francisco Superior Court systems,” the Institute said in a news release.
One reason for the popularity may be the fact that juries can award unlimited damages in liability cases, the study said. In addition, California courts can render judgments against drug makers even if generic versions made by another party are the subject of the lawsuit.
Two California cities, Los Angeles and San Francisco, have been highly rated among states with the “least fair and reasonable litigation climates,” the release said.
Want to get notified whenever we write about Texans for Lawsuit Reform ?
Sign-up Next time we write about Texans for Lawsuit Reform, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.